Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
Vivos Therapeutics (VVOS) Stock Price & Analysis
150 Followers
VVOS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.40 - $48.79
Previous Close$2.66
Volume9.99K
Average Volume (3M)219.62K
Market Cap
$7.27M
Enterprise Value$8.37M
Total Cash (Recent Filing)$1.00M
Total Debt (Recent Filing)$2.10M
Price to Earnings (P/E)-0.3
Beta2.47
Next Earnings
May 13, 2024EPS Estimate
-$1.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.41
Shares Outstanding2,731,270
10 Day Avg. Volume679,495
30 Day Avg. Volume219,616
Standard Deviation1.14
R-Squared0.12
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.28
Price to Sales (P/S)0.45
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit0.84
Enterprise Value/Ebitda3.40
Forecast
1Y Price Target
$8.25Price Target Upside210.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Vivos Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
VVOS FAQ
What was Vivos Therapeutics’s price range in the past 12 months?
Vivos Therapeutics lowest stock price was $2.40 and its highest was $48.79 in the past 12 months.
What is Vivos Therapeutics’s market cap?
Currently, no data Available
When is Vivos Therapeutics’s upcoming earnings report date?
Vivos Therapeutics’s upcoming earnings report date is May 13, 2024 which is in 16 days.
How were Vivos Therapeutics’s earnings last quarter?
Vivos Therapeutics released its earnings results on Mar 28, 2024. The company reported -$3.14 earnings per share for the quarter, missing the consensus estimate of -$1.905 by -$1.235.
Is Vivos Therapeutics overvalued?
According to Wall Street analysts Vivos Therapeutics’s price is currently Undervalued.
Does Vivos Therapeutics pay dividends?
Vivos Therapeutics does not currently pay dividends.
What is Vivos Therapeutics’s EPS estimate?
Vivos Therapeutics’s EPS estimate is -$1.18.
How many shares outstanding does Vivos Therapeutics have?
Vivos Therapeutics has 2,731,270 shares outstanding.
What happened to Vivos Therapeutics’s price movement after its last earnings report?
Vivos Therapeutics reported an EPS of -$3.14 in its last earnings report, missing expectations of -$1.905. Following the earnings report the stock price went down -30.228%.
Which hedge fund is a major shareholder of Vivos Therapeutics?
Among the largest hedge funds holding Vivos Therapeutics’s share is Royce & Associates LLC. It holds Vivos Therapeutics’s shares valued at N/A.
---
Vivos Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.25 (210.15% Upside)
$8.25 (210.15% Upside)
Blogger Sentiment
Bullish
VVOS Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.6%
Last 30 Days ▼ 20.1%
Last 30 Days ▼ 20.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.91%
12-Months-Change
Fundamentals
Return on Equity
-521.22%
Trailing 12-Months
Asset Growth
-21.79%
Trailing 12-Months
Company Description
Vivos Therapeutics
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment of sleep-disordered breathing including mild-to-moderate obstructive sleep apnea resulting from underdeveloped upper and lower jaws.
---
VVOS Earnings Call
Q4 2024
0:00 / 0:00
---
VVOS Stock 12 Months Forecast
Average Price Target
$8.25
▲(210.15% Upside)
Technical Analysis
---